Pharmaceutical manufacturing and distribution of various health products in India.
Annual revenue $968,891 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Deepar Pharmaceuticals

Deepar Pharmaceuticals is a company. Deepar Pharmaceuticals offers products and services including Tablets and Capsules.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $968.89 K (USD)
    26.78
    as on Mar 31, 2020
  • Net Profit
    $1.7 K (USD)
    1.68
    as on Mar 31, 2020
  • EBITDA
    $84.98 K (USD)
    1341.21
    as on Mar 31, 2020
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Deepar Pharmaceuticals

Deepar Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Product name locked
Category locked
Primary

Various tablets are manufactured for addressing health needs, including products like LIZO-600mg Tab and SENIFER-XT Tab

Product name locked
Category locked
Locked

Capsules are produced for medicinal purposes, such as FUNGI 200mg Cap and SENOXY Cap

Funding Insights of Deepar Pharmaceuticals

Premium access

Detailed funding history for Deepar Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Deepar Pharmaceuticals

Investments
Premium access

Investment portfolio details for Deepar Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Deepar Pharmaceuticals

Premium access

Detailed financials for Deepar Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Deepar Pharmaceuticals Comparisons

Deepar Pharmaceuticals Primary company
Description
Pharmaceutical manufacturing and distribution of various hea...
Location
-
Founded Year
-
Annual Revenue
$968.89 K (USD)
Net Profit
$1.7 K (USD)
EBITDA
$84.98 K (USD)
Employees
Not available
Premium access

Peer comparison for Deepar Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Deepar Pharmaceuticals

Premium access

Detailed competitors of Deepar Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Deepar Pharmaceuticals

Premium access

Complete news archive for Deepar Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepar Pharmaceuticals

Annual revenue of Deepar Pharmaceuticals is $968.89K as on Mar 31, 2020.

Deepar Pharmaceuticals is recognized as a pharmaceutical company that was founded in 2009 and incorporated in 2016, with a focus on delivering innovative molecules to enhance healthcare in India. The company is led by its directors who have worked to build strong relationships with doctors and provide quality, affordable medicines. Products such as tablets, capsules, and syrups are manufactured under WHO and GMP certifications, ensuring adherence to high standards. A pan-India presence is maintained to make healthcare solutions accessible, emphasizing quality assurance and customer-focused approaches in operations.

Deepar Pharmaceuticals offers Tablets and Capsules.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available